These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37817087)
1. Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020. Fiebig U; Altmann B; Hauser A; Koppe U; Hanke K; Gunsenheimer-Bartmeyer B; Bremer V; Baumgarten A; Bannert N BMC Infect Dis; 2023 Oct; 23(1):673. PubMed ID: 37817087 [TBL] [Abstract][Full Text] [Related]
2. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses. Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827 [TBL] [Abstract][Full Text] [Related]
3. Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland. Parczewski M; Leszczyszyn-Pynka M; Urbańska A Infect Genet Evol; 2017 Apr; 49():122-129. PubMed ID: 28017912 [TBL] [Abstract][Full Text] [Related]
4. Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018. McClung RP; Oster AM; Ocfemia MCB; Saduvala N; Heneine W; Johnson JA; Hernandez AL Clin Infect Dis; 2022 Mar; 74(6):1055-1062. PubMed ID: 34175948 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017. Yuan D; Du Z; Zhou J; Ye L; Su L; Yang H; Yuan F; Li Y; Liu H; Zhai W; Liang S; Yang S Medicine (Baltimore); 2019 Oct; 98(43):e17585. PubMed ID: 31651864 [TBL] [Abstract][Full Text] [Related]
6. Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012-2020). Alexiev I; Shankar A; Pan Y; Grigorova L; Partsuneva A; Dimitrova R; Gancheva A; Kostadinova A; Elenkov I; Yancheva N; Grozdeva R; Strashimirov D; Stoycheva M; Baltadzhiev I; Doichinova T; Pekova L; Kosmidis M; Emilova R; Nikolova M; Switzer WM Viruses; 2023 Apr; 15(4):. PubMed ID: 37112921 [TBL] [Abstract][Full Text] [Related]
7. [Prevalence of drug resistance in treatment-naive HIV infected men who have sex with men in Guangzhou, 2008-2015]. Han ZG; Zhang YL; Wu H; Gao K; Zhao YT; Gu YZ; Chen YC Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jul; 39(7):977-982. PubMed ID: 30060315 [No Abstract] [Full Text] [Related]
8. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort. Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586 [TBL] [Abstract][Full Text] [Related]
10. HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016-2023). Gao W; Zhou G; Li M; Wang P; Li J; Deng R AIDS Res Ther; 2024 Sep; 21(1):62. PubMed ID: 39272106 [TBL] [Abstract][Full Text] [Related]
11. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain. de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A; J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838 [TBL] [Abstract][Full Text] [Related]
12. Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study. Duwe S; Brunn M; Altmann D; Hamouda O; Schmidt B; Walter H; Pauli G; Kücherer C J Acquir Immune Defic Syndr; 2001 Mar; 26(3):266-73. PubMed ID: 11242200 [TBL] [Abstract][Full Text] [Related]
13. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru. Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888 [TBL] [Abstract][Full Text] [Related]
14. A decade of HIV-1 drug resistance in the United States: trends and characteristics in a large protease/reverse transcriptase and co-receptor tropism database from 2003 to 2012. Paquet AC; Solberg OD; Napolitano LA; Volpe JM; Walworth C; Whitcomb JM; Petropoulos CJ; Haddad M Antivir Ther; 2014; 19(4):435-41. PubMed ID: 24518099 [TBL] [Abstract][Full Text] [Related]
15. [The prevalence of primary HIV-1 drug resistance in newly reported HIV infections in Henan]. Liu J; Xu W; He C; Yan J; Xing H; Xue XJ; Sun DY; Zhu Q; Wang Z Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):643-7. PubMed ID: 27188354 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and Structure of HIV-1 Drug Resistance to Antiretrovirals in the Volga Federal District in 2008-2019. Peksheva O; Kuzovatova E; Parfenova O; Zaytseva N Viruses; 2022 Aug; 14(9):. PubMed ID: 36146704 [TBL] [Abstract][Full Text] [Related]
17. Minority HIV-1 resistant variants in recent infection and in patients who failed first-line antiretroviral therapy with no detectable resistance-associated mutations in Thailand. Le Nguyen H; Pitakpolrat P; Sirivichayakul S; Delaugerre C; Ruxrungtham K J Med Virol; 2012 May; 84(5):713-20. PubMed ID: 22431018 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018. Wagner T; Zuckerman NS; Halperin T; Chemtob D; Levy I; Elbirt D; Shachar E; Olshtain-Pops K; Elinav H; Chowers M; Itsomin V; Riesenberg K; Wax M; Shirazi R; Gozlan Y; Matus N; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O Viruses; 2021 Dec; 14(1):. PubMed ID: 35062274 [TBL] [Abstract][Full Text] [Related]
19. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa. Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774 [TBL] [Abstract][Full Text] [Related]
20. National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014. Hauser A; Hofmann A; Hanke K; Bremer V; Bartmeyer B; Kuecherer C; Bannert N Euro Surveill; 2017 Jan; 22(2):. PubMed ID: 28105988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]